For the Patient: Lenvatinib Other names: LENVIMA

Similar documents
For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Trastuzumab emtansine Other names: KADCYLA

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Sunitinib Other names: SUTENT

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: Mitoxantrone Other names:

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

For the Patient: LUAVPEM

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

ABOUT THIS MEDICATION

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: Methotrexate Other names: MTX

For the Patient: LUAVNP

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: LUAVPG (Carboplatin Option)

For the Patient: ULUAVPMTN

For the Patient: CAP. Capecitabine. Uses:

For the Patient: LUPUPE (Carboplatin Option)

ABOUT THIS MEDICATION

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: LUSCTOP

For the Patient: LUAVPG

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: LUSCPE

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

For the Patient: LUAJPC

For the Patient: LUAVPP

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: LUPUPE

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

ABOUT THIS MEDICATION

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: GOCXCATB

ABOUT THIS MEDICATION

For the Patient: GDP-R Other names: LYGDPR

For the Patient: USMAVFIPI

ABOUT THIS MEDICATION

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

For the Patient: LULAPERT

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: GOOVCATR

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

For the Patient: LUAVDC

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: UMYLDREL

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

Lenvatinib (Lenvima ) ( len-va-ti-nib )

For the Patient: SAAJAP

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

Docetaxel (Taxotere )

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

For the Patient: GUBEP

For the Patient: LUSCCAV

For the Patient: USMAVNIV

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

For the Patient: ACTW Other names: BRAJACTW

ABOUT THIS MEDICATION

INTENDED BENEFITS You are being asked to take these drugs as a treatment to reduce the risk of recurrence of cancer of the stomach or esophagus.

For the Patient: ULUAVPMB

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

Regorafenib (Stivarga )

For the Patient: LUOTPAC

For the Patient: USMAVPEM

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

Treatment Plan: Drugs:

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

Transcription:

For the Patient: Lenvatinib Other names: LENVIMA Lenvatinib (len va' ti nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Tell your doctor if you have ever had an unusual or allergic reaction to lenvatinib before taking lenvatinib. Blood tests, urine tests, and blood pressure measurements may be taken regularly during treatment. The dose and timing of your treatment may be changed based on the test results and/or other side effects. It is important to take lenvatinib exactly as directed by your doctor. Make sure you understand the directions. You may be given capsules of more than one strength to make the right dose. You may take lenvatinib with food or on an empty stomach. If you miss a dose of lenvatinib, take it as soon as you can if it is within 12 hours of the missed dose. If it is more than 12 hours since your missed dose, skip the missed dose and go back to your usual dosing times. If you vomit the dose of lenvatinib within 30 minutes of taking it, repeat the dose. Let your doctor know as a medication to prevent nausea may be required for future doses. Other drugs may interact with lenvatinib. Check with your doctor or pharmacist before you start or stop taking any other drugs. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of lenvatinib. Lenvatinib may decrease fertility in men and women. If you plan to have children, discuss this with your doctor before being treated with lenvatinib. Lenvatinib may damage sperm and may harm the baby if used during pregnancy. It is best to use birth control while being treated with lenvatinib and for one month after your last treatment. Tell your doctor right away if you or your partner becomes pregnant. Do not breastfeed during treatment. Store lenvatinib capsules out of the reach of children, at room temperature, away from heat, light, and moisture. Keep capsules in original blister card packaging until needed. BC Cancer Agency Cancer Drug Manual Page 1 of 6 Lenvatinib

Tell doctors, dentists, and other health professionals that you are being treated with lenvatinib before you receive any treatment from them. If you are planning to have surgery, you should stop lenvatinib before surgery and not restart lenvatinib after surgery until the surgical wound is fully healed. This helps to lower the risk of bleeding and may prevent problems with wound healing after surgery. Side effects are listed in the following table in the order in which they may occur. Tips to help manage the side effects are included. Nausea and vomiting may sometimes occur. Skin rashes may sometimes occur. Minor bleeding, such as nosebleeds, may sometimes occur. You will be given a prescription for antinausea drug(s) to take at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. Eat and drink often in small amounts. Try the ideas in Food Choices to Help Control Nausea.* If the rash is very irritating, call your doctor. Otherwise, be sure to mention it at your next visit. Sit up straight and tip your head slightly forward. Tilting your head back may cause blood to run down your throat. Pinch your nostrils shut between your thumb and forefinger or apply firm pressure against the bleeding nostril for 10 full minutes. After 10 minutes, check to see if your nose is still bleeding. If it is, hold it for 10 more minutes. Stay quiet for a few hours and do not blow your nose for at least 12 hours after the bleeding has stopped. Get emergency help if a nosebleed lasts longer than 20 minutes. BC Cancer Agency Cancer Drug Manual Page 2 of 6 Lenvatinib

Diarrhea commonly occurs. Constipation may sometimes occur. Your platelets may decrease while on lenvatinib. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. High blood pressure commonly occurs. This can happen very quickly after starting treatment. If diarrhea is a problem: Eat and drink often in small amounts. Avoid high fibre foods as outlined in Food Ideas to Help Manage Diarrhea.* Call your doctor. Another medication may be recommended to help control your diarrhea or you may be asked to temporarily stop lenvatinib. Exercise if you can. Try ideas in Suggestions for Dealing with Constipation.* To help prevent bleeding problems: Try not to bruise, cut, or burn yourself. Clean your nose by blowing gently. Do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Some medications such as ASA (e.g., ASPIRIN ) or ibuprofen (e.g., ADVIL ) may increase your risk of bleeding. Do not stop taking any medication that has been prescribed by your doctor (e.g., ASA for your heart). For minor pain, try acetaminophen (e.g., TYLENOL ) first, to a maximum of 4 g (4000 mg) per day, but occasional use of ibuprofen may be acceptable. Your blood pressure may be checked during your visits to your doctor. You may be asked to check your blood pressure frequently between visits. Your doctor may give you medication if your blood pressure is high. Tell your doctor if you are already on blood pressure medication. Your doctor may have to adjust your dose. BC Cancer Agency Cancer Drug Manual Page 3 of 6 Lenvatinib

Abnormal heart rhythm (QT prolongation) rarely occurs. Sore mouth may sometimes occur. Mouth sores can occur on the tongue, the sides of the mouth, or in the throat. Mouth sores or bleeding gums can lead to an infection. Hand-foot skin reaction may sometimes occur during lenvatinib treatment. The palms of your hands and soles of your feet may tingle, become red, numb, painful, or swollen. Skin may also become dry or itchy. You may not be able to do your normal daily activities if blisters, severe pain, or ulcers occur. Headache may sometimes occur. Back, muscle, or joint pain may sometimes occur. Swelling of hands, feet, or lower legs may sometimes occur if your body retains extra fluid. Minimize your risk of abnormal heart rhythm by: Always checking with your pharmacist and doctor about drug interactions when starting a new medication, herbal product, or supplement. Tell your doctor immediately or get emergency help if your heart is beating irregularly or fast, or if you feel faint, lightheaded, or dizzy. Brush your teeth gently after eating and at bedtime with a very soft toothbrush. If your gums bleed, use gauze instead of a brush. Use baking soda instead of toothpaste. Make a mouthwash with ½ teaspoon baking soda or salt in 1 cup warm water and rinse several times a day. Try the ideas in Food Ideas to Try with a Sore Mouth.* Avoid tight-fitting shoes or rubbing pressure to hands and feet, such as that caused by heavy activity. Avoid tight-fitting jewellery. Clean hands and feet with lukewarm water and gently pat to dry; avoid hot water. Apply lanolin-containing creams (e.g., BAG BALM, UDDERLY SMOOTH ) to hands and feet, liberally and often. Tell your cancer doctor or your nurse at the next visit if you have any signs of hand-foot skin reaction as your dose may need to be changed. Take acetaminophen (e.g., TYLENOL ) every 4-6 hours if needed, to a maximum of 4 g (4000 mg) per day. You may take acetaminophen (e.g., TYLENOL ) every 4-6 hours to a maximum of 4 g (4000 mg) per day. If swelling is a problem: Elevate your feet when sitting. Avoid tight clothing. BC Cancer Agency Cancer Drug Manual Page 4 of 6 Lenvatinib

You may sometimes have trouble sleeping. Taste alteration may sometimes occur. Loss of appetite and weight loss are common. Tiredness and lack of energy may sometimes occur. Hair loss sometimes occurs with lenvatinib. Hair will grow back once you stop treatment with lenvatinib. Blood clots may rarely occur. Signs to watch for include tenderness or hardness over a vein, calf tenderness, sudden onset of cough, chest pain, or shortness of breath. Talk to your doctor if you continue to have trouble sleeping. This will return to normal when you stop taking lenvatinib. Try the ideas in Food Ideas to Cope with Taste and Smell Changes.* Try the ideas in Food Ideas to Help with Decreased Appetite.* Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your Bank to Energy Savings: Helping People with Cancer Handle Fatigue.* If hair loss is a problem, refer to For the Patient: Hair Loss Due to Chemotherapy.* To help prevent blood clots: Keep active. Avoid tight clothing. Do not sit with your legs crossed at the knees. *Please ask your chemotherapy nurse or pharmacist for a copy. STOP TAKING LENVATINIB AND SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of a stroke such as sudden onset of severe headache, eyesight changes, slurred speech, loss of coordination, weakness or numbness in arm or leg. Signs of a blood clot such as tenderness or hardness over a vein, calf swelling and tenderness, sudden onset of cough, chest pain, or shortness of breath. Signs of bleeding problems such as black, tarry stools; blood in urine; pinpoint red spots on skin; extensive bruising. Signs of heart problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath, swelling of feet or lower legs, or fainting. Severe headache that does not go away, or occurs with vomiting, confusion, seizures, or changes in eyesight. Sudden abdominal pain or tenderness. Uncontrolled nausea, vomiting, or diarrhea. BC Cancer Agency Cancer Drug Manual Page 5 of 6 Lenvatinib

SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Signs of liver problems such as yellow eyes or skin, white or clay-coloured stools. Signs of kidney problems such as lower back or side pain, swelling of feet or lower legs. CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE OR BOTHER YOU: Increased sore throat or mouth that makes it difficult to swallow comfortably. Unusual tiredness or weakness. Headache or pain not controlled with acetaminophen (e.g., TYLENOL ). Easy bruising or minor bleeding. Light-headedness, dizziness, or fainting. Flatulence (passing gas) or upset stomach. Taste changes or dry mouth. Cough, hoarseness, or trouble speaking. REPORT ADDITIONAL PROBLEMS TO YOUR DOCTOR BC Cancer Agency Cancer Drug Manual Page 6 of 6 Lenvatinib